Your browser doesn't support javascript.
loading
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.
Fehringer, Gordon; Kraft, Peter; Pharoah, Paul D; Eeles, Rosalind A; Chatterjee, Nilanjan; Schumacher, Fredrick R; Schildkraut, Joellen M; Lindström, Sara; Brennan, Paul; Bickeböller, Heike; Houlston, Richard S; Landi, Maria Teresa; Caporaso, Neil; Risch, Angela; Amin Al Olama, Ali; Berndt, Sonja I; Giovannucci, Edward L; Grönberg, Henrik; Kote-Jarai, Zsofia; Ma, Jing; Muir, Kenneth; Stampfer, Meir J; Stevens, Victoria L; Wiklund, Fredrik; Willett, Walter C; Goode, Ellen L; Permuth, Jennifer B; Risch, Harvey A; Reid, Brett M; Bezieau, Stephane; Brenner, Hermann; Chan, Andrew T; Chang-Claude, Jenny; Hudson, Thomas J; Kocarnik, Jonathan K; Newcomb, Polly A; Schoen, Robert E; Slattery, Martha L; White, Emily; Adank, Muriel A; Ahsan, Habibul; Aittomäki, Kristiina; Baglietto, Laura; Blomquist, Carl; Canzian, Federico; Czene, Kamila; Dos-Santos-Silva, Isabel; Eliassen, A Heather; Figueroa, Jonine D; Flesch-Janys, Dieter.
Afiliação
  • Fehringer G; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.
  • Kraft P; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Pharoah PD; University of Cambridge, Cambridge, United Kingdom.
  • Eeles RA; Institute of Cancer Research, London, United Kingdom.
  • Chatterjee N; National Cancer Instititute, Bethesda, Maryland.
  • Schumacher FR; University of Southern California, Los Angeles, California.
  • Schildkraut JM; University of Virginia, Charlottesville, Virginia.
  • Lindström S; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Brennan P; International Agency for Research on Cancer, Lyon, France.
  • Bickeböller H; University of Göttingen, Medical School, Göttingen, Germany.
  • Houlston RS; Institute of Cancer Research, London, United Kingdom.
  • Landi MT; National Cancer Instititute, Bethesda, Maryland.
  • Caporaso N; National Cancer Instititute, Bethesda, Maryland.
  • Risch A; Division of Cancer Genetics/Epigenetics, Department of Molecular Biology, University of Salzburg, Salzburg, Austria. Division of Epigenomics and Cancer Risk Factors, DKFZ - German Cancer Research Center, Heidelberg, Germany. Translational Lung Research Center Heidelberg (TLRC-H), German Center for L
  • Amin Al Olama A; Cambridge University, Cambridge, United Kingdom.
  • Berndt SI; National Cancer Instititute, Bethesda, Maryland.
  • Giovannucci EL; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Grönberg H; Karolinska Institutet, Stockholm, Sweden.
  • Kote-Jarai Z; Institute of Cancer Research, London, United Kingdom.
  • Ma J; Harvard Medical School, Boston Massachusetts. Brigham and Women's Hospital, Boston, Massachusetts.
  • Muir K; University of Manchester, Manchester, United Kingdom. The University of Warwick, Coventry, United Kingdom.
  • Stampfer MJ; Harvard Medical School, Boston Massachusetts.
  • Stevens VL; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia.
  • Wiklund F; Karolinska Institutet, Stockholm, Sweden.
  • Willett WC; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Goode EL; Mayo Clinic, Rochester, Minnesota.
  • Permuth JB; Moffitt Cancer Center, Tampa, Florida.
  • Risch HA; Yale School of Public Health, New Haven, Connecticut.
  • Reid BM; Moffitt Cancer Center, Tampa, Florida.
  • Bezieau S; Service de Génétique Médicale, Nantes, France.
  • Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chan AT; Massachusetts General Hospital, Boston, Massachusetts.
  • Chang-Claude J; National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hudson TJ; Ontario Institute for Cancer Research, Toronto, Ontario.
  • Kocarnik JK; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Newcomb PA; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Schoen RE; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Slattery ML; University of Utah Health Sciences Center, Salt Lake City, Utah.
  • White E; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Adank MA; VU University Medical Center, Amsterdam, the Netherlands.
  • Ahsan H; University of Chicago, Chicago, Illinois.
  • Aittomäki K; University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Baglietto L; The University of Melbourne, Melbourne, Victoria, Australia.
  • Blomquist C; University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Czene K; Karolinska Institutet, Stockholm, Sweden.
  • Dos-Santos-Silva I; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Eliassen AH; Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Harvard Medical School, Boston Massachusetts.
  • Figueroa JD; National Cancer Instititute, Bethesda, Maryland.
  • Flesch-Janys D; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Cancer Res ; 76(17): 5103-14, 2016 09 01.
Article em En | MEDLINE | ID: mdl-27197191
ABSTRACT
Identifying genetic variants with pleiotropic associations can uncover common pathways influencing multiple cancers. We took a two-stage approach to conduct genome-wide association studies for lung, ovary, breast, prostate, and colorectal cancer from the GAME-ON/GECCO Network (61,851 cases, 61,820 controls) to identify pleiotropic loci. Findings were replicated in independent association studies (55,789 cases, 330,490 controls). We identified a novel pleiotropic association at 1q22 involving breast and lung squamous cell carcinoma, with eQTL analysis showing an association with ADAM15/THBS3 gene expression in lung. We also identified a known breast cancer locus CASP8/ALS2CR12 associated with prostate cancer, a known cancer locus at CDKN2B-AS1 with different variants associated with lung adenocarcinoma and prostate cancer, and confirmed the associations of a breast BRCA2 locus with lung and serous ovarian cancer. This is the largest study to date examining pleiotropy across multiple cancer-associated loci, identifying common mechanisms of cancer development and progression. Cancer Res; 76(17); 5103-14. ©2016 AACR.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Próstata / Neoplasias da Mama / Neoplasias Colorretais / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Próstata / Neoplasias da Mama / Neoplasias Colorretais / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá
...